AS

Abhishek Shivaji Salunke

Active Director Designated Partner DIN 11554683
DIN 11554683 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Shivaji Salunke

Data last updated:

Abhishek Shivaji Salunke is a Designated Partner at Celcos Lifesciences Llp (since 2026). The company operates in Pharma.

DIN 11554683
Primary Designation Designated Partner
Industry Pharma
First Appointment 18 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Feb 20262026Active

Board colleagues of Abhishek Shivaji Salunke

NameDINCompanyDesignation
Dnyansagar Popat Salunke11554682Celcos Lifesciences LlpDesignated Partner
Shubham Shankar Nimje11554681Celcos Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Celcos Lifesciences Llp
Premium access

Shareholding and investment profile for Abhishek Shivaji Salunke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Shivaji Salunke

Abhishek Shivaji Salunke currently holds 1 directorship: Celcos Lifesciences Llp (Designated Partner, since 18 Feb 2026).

Abhishek Shivaji Salunke was first appointed on 18 Feb 2026 as Designated Partner at Celcos Lifesciences Llp.

The current boards of Abhishek Shivaji Salunke's companies include Dnyansagar Popat Salunke (Celcos Lifesciences Llp), Shubham Shankar Nimje (Celcos Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available